Cargando…

Retrospective cohort study of statin prescribing for primary prevention among people living with HIV

OBJECTIVE: To compare statin prescribing rates between intermediate-risk people living with human immunodeficiency virus (HIV; PLWH) and intermediate-risk patients without a diagnosis of HIV for primary prevention of atherosclerotic cardiovascular disease (ASCVD). METHODS: Retrospective cohort study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nardolillo, Joseph A, Marrs, Joel C, Anderson, Sarah L, Hanratty, Rebecca, Saseen, Joseph J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278443/ https://www.ncbi.nlm.nih.gov/pubmed/34290861 http://dx.doi.org/10.1177/20480040211031068

Ejemplares similares

Factors affecting statin uptake among people living with HIV: primary care provider perspectives
por: Ober, Allison J., et al.
Publicado: (2021)

Factors predicting statin prescribing for primary prevention: a historical cohort study
por: Finnikin, Samuel, et al.
Publicado: (2021)

Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States
por: Boettiger, David C, et al.
Publicado: (2021)

Statins for primary cardiovascular disease prevention among people with HIV: emergent directions
por: Fitch, Kathleen V., et al.
Publicado: (2022)

Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis
por: Fleetcroft, Robert, et al.
Publicado: (2014)

Effects of Race on Statin Prescribing for Primary Prevention With High Atherosclerotic Cardiovascular Disease Risk in a Large Healthcare System
por: Dorsch, Michael P., et al.
Publicado: (2019)

Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost‐effectiveness analysis
por: Boettiger, David C, et al.
Publicado: (2020)

Price versus clinical guidelines in primary care statin prescribing: a retrospective cohort study and cost simulation model
por: De Zarate, Matias Ortiz, et al.
Publicado: (2021)

Zolpidem prescribing practices before and after Food and Drug Administration required product labeling changes
por: Norman, Jessica L, et al.
Publicado: (2017)

The use of statins in primary prevention
por: Rosian, Ingrid, et al.
Publicado: (2006)

Prescribing pattern of statins for primary prevention of cardiovascular diseases in patients with type 2 diabetes: insights from Ethiopia
por: Demoz, Gebre Teklemariam, et al.
Publicado: (2019)

Population Impact & Efficiency of Benefit‐Targeted Versus Risk‐Targeted Statin Prescribing for Primary Prevention of Cardiovascular Disease
por: Pletcher, Mark J., et al.
Publicado: (2017)

Statin prescribing for people with severe mental illnesses: a staggered cohort study of ‘real-world’ impacts
por: Blackburn, R, et al.
Publicado: (2017)

Impact of lowering the risk threshold for statin treatment on statin prescribing: a descriptive study in English primary care
por: Pate, Alexander, et al.
Publicado: (2020)

2251. Comparing Statin Prescribing Rates in Eligible HIV vs. Non-HIV-Infected Patients
por: Blackman, Alison, et al.
Publicado: (2018)

Association of Primary Care Providers’ Beliefs of Statins for Primary Prevention and Statin Prescription
por: Clough, Jeffrey D., et al.
Publicado: (2019)

Patient-Reported Reasons for Not Using Primary Prevention Statin Therapy
por: DeWitt, Cassandra M., et al.
Publicado: (2020)

Landscape of TB Infection and Prevention among People Living with HIV
por: Vasiliu, Anca, et al.
Publicado: (2022)

Assessment of Primary Care Appointment Times and Appropriate Prescribing of Statins for At-Risk Patients
por: Hare, Allison J., et al.
Publicado: (2021)

Effectiveness of Statins as Primary Prevention in People With Different Cardiovascular Risk: A Population‐Based Cohort Study
por: Garcia‐Gil, Maria, et al.
Publicado: (2018)

Statins for primary cardiovascular prevention in the elderly
por: Pedro-Botet, Juan, et al.
Publicado: (2015)

Statins in primary prevention: is the enthusiasm justified?
por: Chopra, Arun K., et al.
Publicado: (2020)

Prescribing of antipsychotics among people with recorded personality disorder in primary care: a retrospective nationwide cohort study using The Health Improvement Network primary care database
por: Hardoon, Sarah, et al.
Publicado: (2022)

Factors Associated with the Prescribing of High-Intensity Statins
por: Chaure-Pardos, Armando, et al.
Publicado: (2020)

Diabetes: how to manage cardiovascular risk in secondary prevention patients
por: Anderson, Sarah L, et al.
Publicado: (2022)

Statin use and all-cause mortality in people living with HIV: a systematic review and meta-analysis
por: Uthman, Olalekan A., et al.
Publicado: (2018)

Preventative behaviours and COVID-19 infection in a Canadian cohort of people living with HIV
por: Hammond, Keely, et al.
Publicado: (2023)

Evaluation of a Pharmacist-Led Intervention to Improve Statin Use in Persons with Diabetes
por: Anderson, Sarah L., et al.
Publicado: (2020)

Survival Benefits of Statins for Primary Prevention: A Cohort Study
por: Gitsels, Lisanne A., et al.
Publicado: (2016)

Adherence to Statins in Primary Prevention: Yearly Adherence Changes and Outcomes
por: Slejko, Julia F., et al.
Publicado: (2014)

Prescribing issues experienced by people living with phenylketonuria in the UK
por: Ford, Suzanne, et al.
Publicado: (2019)

Statins for primary prevention of cardiovascular disease and the risk of acute kidney injury
por: Coste, Joël, et al.
Publicado: (2019)

Coverage of isoniazid preventive therapy among people living with HIV; A retrospective cohort study in Tanzania (2012-2016)
por: Maokola, Werner, et al.
Publicado: (2021)

Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization
por: Brunet, Laurence, et al.
Publicado: (2021)

Optimizing secondary prevention: Statin prescribing across East and West London in accordance with NICE guidelines
por: Shakur, Rameen, et al.
Publicado: (2011)

Evaluating an implementation strategy in cardiovascular prevention to improve prescribing of statins in Germany: an intention to treat analysis
por: Keller, Heidemarie, et al.
Publicado: (2013)

To JUPITER and beyond: Statins, inflammation, and primary prevention
por: Rao, Ajay D, et al.
Publicado: (2010)

Statins for the Primary Prevention of Coronary Heart Disease
por: Li, Min, et al.
Publicado: (2019)

The potential impact of new national guidance on primary prevention of cardiovascular disease in people living with HIV
por: Ahmed, Nadia, et al.
Publicado: (2014)

Retrospective evaluation of cotrimoxazole use as preventive therapy in people living with HIV/AIDS in Boru Meda Hospital
por: Geresu, Berhanu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8ltg3td53dehd80ufh67rgcv9n